| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mL |
|
||
| Other Sizes |
| Targets |
Hexaethylene glycol monododecyl ether does not have a defined pharmacological target as it is a nonionic surfactant and biochemical reagent. The compound is commonly used as a surfactant and emulsifier. It plays a crucial role in formulating drug delivery systems and enhancing drug solubility. It is used in pharmaceutical research and drug development.
|
|---|---|
| ln Vitro |
No specific in vitro pharmacological activity data are available for Hexaethylene glycol monododecyl ether as a drug candidate. In research settings, the compound is used as a surfactant, emulsifier, and in drug delivery system formulation. Its activity is assessed in terms of surfactant properties and formulation performance rather than biological activity.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for Hexaethylene glycol monododecyl ether as a therapeutic agent. The compound is used as a surfactant and emulsifier in pharmaceutical research and drug development. It is not administered to animals for pharmacological evaluation. Its applications are limited to biochemical and pharmaceutical research.
|
| Enzyme Assay |
For non-cellular assays, Hexaethylene glycol monododecyl ether is characterized by standard analytical techniques including HPLC, NMR, and mass spectrometry to confirm identity and purity. The compound can be evaluated for its surfactant properties including critical micelle concentration and surface activity. Typical protocols involve preparing solutions of the compound in aqueous buffers. Purity: ≥97% to ≥98%.
|
| Cell Assay |
For in vitro cell-based studies, Hexaethylene glycol monododecyl ether may be used in drug delivery formulation studies. The compound can be used to formulate liposomes or other delivery vehicles. Cells are cultured under standard conditions and treated with formulations containing the surfactant. Appropriate controls should be included in the experimental design.
|
| Animal Protocol |
For in vivo animal studies, Hexaethylene glycol monododecyl ether can be formulated using standard injection vehicles. The compound is a solid at room temperature. Dosing solutions should be freshly prepared and administered according to specific protocols with appropriate control groups. The compound is used in pharmaceutical research and drug development.
|
| ADME/Pharmacokinetics |
Hexaethylene glycol monododecyl ether has a molecular weight of 450.65 and molecular formula C24H50O7. It appears as a solid at room temperature. Purity: ≥97% to ≥98%. Storage: keep in a cool, dry place protected from light and moisture. The compound is stable under recommended storage conditions.
|
| Toxicity/Toxicokinetics |
Toxicity Summary
The CIR panel concluded that the following alkyl polyethylene glycol ethers are safe under current usage methods and concentrations, and when formulated as non-irritating. This assessment also aims to cover potential future cosmetic ingredients containing alkyl polyethylene glycol ethers, which differ from those described herein only in the number of repeating glycol units… Lauryl ether-6… Safe for use in cosmetics under specific conditions. Hexaethylene glycol monododecyl ether is for research use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD50 values and detailed toxicological profiles have not been extensively reported. |
| Additional Infomation |
See also: Laureth-6 (Notes moved to).
Hexaethylene glycol monododecyl ether (CAS 3055-96-7) is also known as C12E6. It is a nonionic surfactant widely utilized in biochemical and biophysical research. It plays a crucial role in formulating drug delivery systems and enhancing drug solubility. It is used in pharmaceutical research and drug development. |
| Molecular Formula |
C24H50O7
|
|---|---|
| Molecular Weight |
450.65
|
| Exact Mass |
450.355
|
| CAS # |
3055-96-7
|
| PubChem CID |
18282
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.0±0.1 g/cm3
|
| Boiling Point |
521.0±45.0 °C at 760 mmHg
|
| Melting Point |
27ºC
|
| Flash Point |
268.9±28.7 °C
|
| Vapour Pressure |
0.0±3.1 mmHg at 25°C
|
| Index of Refraction |
1.456
|
| LogP |
3.26
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
7
|
| Rotatable Bond Count |
28
|
| Heavy Atom Count |
31
|
| Complexity |
306
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO
|
| InChi Key |
OJCFEGKCRWEVSN-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C24H50O7/c1-2-3-4-5-6-7-8-9-10-11-13-26-15-17-28-19-21-30-23-24-31-22-20-29-18-16-27-14-12-25/h25H,2-24H2,1H3
|
| Chemical Name |
2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2190 mL | 11.0951 mL | 22.1902 mL | |
| 5 mM | 0.4438 mL | 2.2190 mL | 4.4380 mL | |
| 10 mM | 0.2219 mL | 1.1095 mL | 2.2190 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
